PROPANC BIOPHARMA, INC. Stock Issued During Period, Value, Restricted Stock Award, Gross
PROPANC BIOPHARMA, INC. (PPCB) reported Stock Issued During Period, Value, Restricted Stock Award, Gross of $70.00 thousand for the 0-month period ending 2017-12-29, per its 10-Q filed 2018-02-09.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross · last filed 2018-02-09
- 2017-12-29: Stock Issued During Period, Value, Restricted Stock Award, Gross 0 month $70.00K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 0 month |
|---|---|
| 2017-12-29 | $70.00K 10-Q · filed 2018-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |